Pancrelipase Lipase: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Pancrelipase Lipase. Educational only — not medical advice.
Labeled uses
VIOKACE, in combination with a proton pump inhibitor, is indicated for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy in adults.
Source: FDA labeling via NIH DailyMed (set 58bdb8de…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.